HLB Life Science Co Debt 2024

HLB Life Science Co Aktienanalyse

What does HLB Life Science Co do?

HLB Life Science Co., Ltd. is a leading company in the research, development, and production of biotechnological and pharmaceutical products. The company was founded in 2015 in Seoul, South Korea. Due to the founders' extensive experience in the field of life science and biotechnology, HLB Life Science has quickly established itself as a key player in the industry. HLB Life Science's business model is based on the development and production of innovative biotechnological and pharmaceutical products, as well as collaboration with other companies and research institutions. The aim is to improve people's quality of life by providing effective and safe medications and therapies. The company is divided into various divisions. The Biopharmaceuticals division includes the development and production of biotechnological products such as antibodies, proteins, vaccines, and diagnostics. The Pharmaceuticals division develops and produces advanced drugs in the field of oncology, immunology, and neurology. The Clinical Research Services division offers contract research services in the field of clinical studies to test the effectiveness and safety of drugs. In addition, HLB Life Science Co., Ltd. is also active in the Nutra-Pharmaceuticals division, specializing in the development and production of dietary supplements. HLB Life Science offers various products tailored to the needs of patients. In the field of Biopharmaceuticals, for example, the company produces antibodies and proteins for the treatment of cancer, inflammatory diseases, and infections. Another innovative product is a fully humanized antibody against the hepatitis B virus, which is one of the most common liver diseases. In the Pharmaceuticals field, HLB Life Science offers innovative drugs for the treatment of cancer, autoimmune diseases, and neurological disorders. In the Nutra-Pharmaceuticals field, the company offers dietary supplements based on natural ingredients that can strengthen the immune system. HLB Life Science Co., Ltd. is known in the industry for its innovative strength and excellent research results. The company places great emphasis on continuous research and development to develop innovative products and continuously improve existing products. Due to their outstanding products and services, HLB Life Science has already exported to various countries worldwide and has thus played a significant role in the global market. Looking to the future, HLB Life Science Co., Ltd. continues to focus on innovative research and development, as well as close collaboration with universities and research institutions. The company aims to improve people's health and well-being through effective and safe medications and therapies. HLB Life Science Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding HLB Life Science Co's Debt Structure

HLB Life Science Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing HLB Life Science Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to HLB Life Science Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in HLB Life Science Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about HLB Life Science Co stock

What is the debt of HLB Life Science Co this year?

HLB Life Science Co has a debt level of 0 KRW this year.

What was the debt of HLB Life Science Co compared to the previous year?

The debt of HLB Life Science Co has increased by -100% compared to the previous year dropped.

What are the consequences of high debt for investors in HLB Life Science Co?

High debt can pose a risk for investors of HLB Life Science Co, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of HLB Life Science Co?

Low debt means that HLB Life Science Co has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from HLB Life Science Co affect the company?

An increase in debt of HLB Life Science Co can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of HLB Life Science Co affect the company?

A reduction in debt of HLB Life Science Co can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of HLB Life Science Co?

Some factors that can influence the debt of HLB Life Science Co include investments, acquisitions, operating costs, and revenue development.

Why are the debts of HLB Life Science Co so important for investors?

The debts of HLB Life Science Co are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can HLB Life Science Co take to change the debt?

To change the debt, HLB Life Science Co can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does HLB Life Science Co pay?

Over the past 12 months, HLB Life Science Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, HLB Life Science Co is expected to pay a dividend of 0 KRW.

What is the dividend yield of HLB Life Science Co?

The current dividend yield of HLB Life Science Co is .

When does HLB Life Science Co pay dividends?

HLB Life Science Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of HLB Life Science Co?

HLB Life Science Co paid dividends every year for the past 0 years.

What is the dividend of HLB Life Science Co?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is HLB Life Science Co located?

HLB Life Science Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von HLB Life Science Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of HLB Life Science Co from 8/7/2024 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 8/7/2024.

When did HLB Life Science Co pay the last dividend?

The last dividend was paid out on 8/7/2024.

What was the dividend of HLB Life Science Co in the year 2023?

In the year 2023, HLB Life Science Co distributed 0 KRW as dividends.

In which currency does HLB Life Science Co pay out the dividend?

The dividends of HLB Life Science Co are distributed in KRW.